Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Brocade Communications Systems, Inc. (NASDAQ: BRCD) shares declined 0.21 percent to close at $9.60 a share Tuesday. The stock traded between $9.54 and $9.69 on volume 6.06 million shares traded. The company reported GAAP diluted earnings per share of $0.18 for the first quarter of fiscal 2014, compared to a loss of $0.05 per share a year ago. Shares of Brocade are up approximately 8.0 percent year-to-date.
Get more information on Brocade free access to the in-depth equity report at:
Navidea Biopharmaceuticals Inc. (NYSEMKT: NAVB) shares gained 3.74 percent to close at $1.94 a share Tuesday. The stock traded between $1.91 and $1.98 on volume 1.32 million shares traded. The company announced that the FDA has accepted the Supplemental New Drug Application and granted a Priority Review for the expanded use of Lymphoseek. Shares of Navidea are up approximately 10.0 percent year-to-date.
Get more information on Navidea and free access to the in-depth equity report at:
Prana Biotechnology Limited (NASDAQ: PRAN) shares soared 39.31 percent to close at $10.10 a share Tuesday. The stock traded between $7.80 and $10.74 on volume of 25.29 million shares traded. The company announced that it has met its primary endpoint in a recent Phase 2 clinical trial of PBT2 as a treatment for Huntington disease. Shares of Prana Biotechnology are up approximately 45.0 percent year-to-date.
Get more information on Prana Biotechnology and free access to the in-depth equity report at:
Stryker Corporation (NYSE: SYK) shares declined 0.88 percent to close at $82.62 a share Tuesday. The stock traded between $82.54 and $83.82 on volume of 1.81 million shares traded. The company announced that it has acquired privately held Berchtold Holding, AG for approximately $172.0 million. Shares of Stryker are up approximately 10.0 percent year-to-date.
Get more information on Stryker and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities